Tvardi Therapeutics to Present at the Morgan Stanley 20th Annual Global Healthcare Conference
HOUSTON–(BUSINESS WIRE)–#IPF–Tvardi Therapeutics, Inc. (“Tvardi”), a privately held, clinical-stage biopharmaceutical company focused on the development of STAT3 inhibitors, announced that the management team will participate in a fireside chat at the Morgan Stanley 20th Annual Global Healthcare Conference at 1:30 p.m. ET as well as in one-on-one meetings in New York City on Wednesday, September … [Read more…]
